The potential of HDAC inhibitors as cognitive enhancers - PubMed (original) (raw)
Review
The potential of HDAC inhibitors as cognitive enhancers
Johannes Gräff et al. Annu Rev Pharmacol Toxicol. 2013.
Abstract
Histone acetylation is a prominent epigenetic modification of the central nervous system that is unequivocally associated with an increase in the rate of gene transcription. Because gene transcription, in turn, plays an important role in long-lasting forms of memory, histone acetylation generally favors long-term memory, whereas histone deacetylation impinges on it. Histone acetylation is also amenable to pharmacological interventions-predominantly by the use of histone deacetylase (HDAC) inhibitors-and has therefore spurred considerable interest as a putative target of cognitive enhancement. Because of the ubiquitous presence of histone acetylation, HDAC inhibitors have great potential not only to treat cognitive impairment resulting from neurodevelopmental and neurodegenerative disorders but also to serve as cognitive enhancers for the cognitively healthy. In this review, we summarize the state of the art of HDAC inhibitors as cognitive treatments or cognitive enhancers; describe a new model of their mode of action, epigenetic priming; and caution against their unsupervised usage, despite their overall great promise.
Similar articles
- Histone Deacetylase Inhibitors as Cognitive Enhancers and Modifiers of Mood and Behavior.
Pal D, Sahu P, Mishra AK, Hagelgans A, Sukocheva O. Pal D, et al. Curr Drug Targets. 2023;24(9):728-750. doi: 10.2174/1389450124666221207090108. Curr Drug Targets. 2023. PMID: 36475351 Review. - Targeting the correct HDAC(s) to treat cognitive disorders.
Fischer A, Sananbenesi F, Mungenast A, Tsai LH. Fischer A, et al. Trends Pharmacol Sci. 2010 Dec;31(12):605-17. doi: 10.1016/j.tips.2010.09.003. Epub 2010 Oct 25. Trends Pharmacol Sci. 2010. PMID: 20980063 Review. - HDAC modulation and cell death in the clinic.
Dell'Aversana C, Lepore I, Altucci L. Dell'Aversana C, et al. Exp Cell Res. 2012 Jul 1;318(11):1229-44. doi: 10.1016/j.yexcr.2012.01.025. Epub 2012 Feb 3. Exp Cell Res. 2012. PMID: 22336671 Review. - Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
Konsoula Z, Barile FA. Konsoula Z, et al. J Pharmacol Toxicol Methods. 2012 Nov-Dec;66(3):215-20. doi: 10.1016/j.vascn.2012.08.001. Epub 2012 Aug 10. J Pharmacol Toxicol Methods. 2012. PMID: 22902970 Review. - Targeting histone deacetylase in thyroid cancer.
Russo D, Durante C, Bulotta S, Puppin C, Puxeddu E, Filetti S, Damante G. Russo D, et al. Expert Opin Ther Targets. 2013 Feb;17(2):179-93. doi: 10.1517/14728222.2013.740013. Epub 2012 Dec 13. Expert Opin Ther Targets. 2013. PMID: 23234477 Review.
Cited by
- Histone modifications change with age, dietary restriction and rapamycin treatment in mouse brain.
Gong H, Qian H, Ertl R, Astle CM, Wang GG, Harrison DE, Xu X. Gong H, et al. Oncotarget. 2015 Jun 30;6(18):15882-90. doi: 10.18632/oncotarget.4137. Oncotarget. 2015. PMID: 26021816 Free PMC article. - Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.
Valor LM, Viosca J, Lopez-Atalaya JP, Barco A. Valor LM, et al. Curr Pharm Des. 2013;19(28):5051-64. doi: 10.2174/13816128113199990382. Curr Pharm Des. 2013. PMID: 23448461 Free PMC article. Review. - Inhibition of Histone Methyltransferases EHMT1/2 Reverses Amyloid-β-Induced Loss of AMPAR Currents in Human Stem Cell-Derived Cortical Neurons.
Lin L, Liu A, Li H, Feng J, Yan Z. Lin L, et al. J Alzheimers Dis. 2019;70(4):1175-1185. doi: 10.3233/JAD-190190. J Alzheimers Dis. 2019. PMID: 31322566 Free PMC article. - Histone acetyltransferase CBP-related H3K23 acetylation contributes to courtship learning in Drosophila.
Li KL, Zhang L, Yang XM, Fang Q, Yin XF, Wei HM, Zhou T, Li YB, Chen XL, Tang F, Li YH, Chang JF, Li W, Sun F. Li KL, et al. BMC Dev Biol. 2018 Nov 20;18(1):20. doi: 10.1186/s12861-018-0179-z. BMC Dev Biol. 2018. PMID: 30458702 Free PMC article. - Nutraceuticals and Physical Activity as Antidepressants: The Central Role of the Gut Microbiota.
Donati Zeppa S, Ferrini F, Agostini D, Amatori S, Barbieri E, Piccoli G, Sestili P, Stocchi V. Donati Zeppa S, et al. Antioxidants (Basel). 2022 Jan 26;11(2):236. doi: 10.3390/antiox11020236. Antioxidants (Basel). 2022. PMID: 35204119 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources